Low-Fat Diet Alleviates Perimenopausal Symptoms by Reducing Methylation Levels of PDE4C and NPAS2 Genes: A Randomized Controlled Trial
article
OA: gold
CC0
Abstract
Background: Perimenopausal syndrome (PMS) significantly impacts the quality of life in women during the perimenopausal phase. Despite being the primary treatment, hormone replacement therapy has notable limitations. Consequently, dietary interventions, particularly low-fat diets, have garnered international attention as an alternative. Methods: The prospective Randomized Controlled Trial (RCT), approved by the Ethics Committee of the Affiliated Hospital of Guizhou Medical University, enrolled 62 perimenopausal women. Participants were divided into two groups: a low-fat diet group and a menopausal hormone therapy (MHT) group, with interventions lasting eight weeks. Both groups underwent assessments for perimenopausal symptoms, lipid profile, and oxidative stress markers, including superoxide dismutase (SOD), malondialdehyde (MDA), and reactive oxygen species (ROS), before and after the interventions. Additionally, DNA methylation levels of the PDE4C and NPAS2 genes were measured in 10 women from the low-fat diet group before and after the intervention. Results: Both the low-fat diet and hormone supplementation improved specific perimenopausal symptoms, reduced specific lipid levels, and had a positive effect on oxidative stress markers. The low-fat diet proved more effective than hormone replacement in improving the serum lipid profile and also resulted in reductions in methylation at specific sites of the PDE4C and NPAS2 genes. Conclusions: A low-fat diet may alleviate perimenopausal symptoms, lower lipid levels, and alter gene methylation sites. Clinical Trial Registration: The study has been registered on https://www.chictr.org.cn/ (registration number: ChiCTR2400084007).
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (53)
- W960095293 via openalex
- W1603785147 via openalex
- W1692222554 via openalex
- W1913092771 via openalex
- W1964510976 via openalex
- W1965359283 via openalex
- W1975488611 via openalex
- W2007824063 via openalex
- W2008656621 via openalex
- W2011427676 via openalex
- W2022152889 via openalex
- W2056268934 via openalex
- W2057539322 via openalex
- W2096465668 via openalex
- W2136691282 via openalex
- W2137843473 via openalex
- W2154394182 via openalex
- W2168008031 via openalex
- W2238107968 via openalex
- W2310573710 via openalex
- W2317195238 via openalex
- W2398627645 via openalex
- W2432673560 via openalex
- W2484467488 via openalex
- W2511475183 via openalex
- W2512580587 via openalex
- W2520710800 via openalex
- W2553007848 via openalex
- W2744797634 via openalex
- W2761338549 via openalex
- W2773327522 via openalex
- W2786978739 via openalex
- W2804925453 via openalex
- W2806033591 via openalex
- W2830909571 via openalex
- W2885176254 via openalex
- W2896522933 via openalex
- W2897406695 via openalex
- W2941933916 via openalex
- W2986136480 via openalex
- W2999113885 via openalex
- W2999815207 via openalex
- W3017780338 via openalex
- W3018773781 via openalex
- W3025691650 via openalex
- W3102665598 via openalex
- W3139529615 via openalex
- W3149804071 via openalex
- W3175614639 via openalex
- W3209565272 via openalex
- W4245740148 via openalex
- W4313644710 via openalex
- W4385651682 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK